Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
0.5360
Dollar change
-0.0383
Percentage change
-6.67
%
IndexRUT P/E- EPS (ttm)-0.84 Insider Own15.43% Shs Outstand59.11M Perf Week-7.90%
Market Cap29.57M Forward P/E- EPS next Y-0.83 Insider Trans0.00% Shs Float49.99M Perf Month2.94%
Income-39.70M PEG- EPS next Q-0.19 Inst Own84.38% Short Float11.90% Perf Quarter-74.84%
Sales0.00M P/S- EPS this Y41.26% Inst Trans27.64% Short Ratio5.09 Perf Half Y-85.51%
Book/sh1.48 P/B0.36 EPS next Y-5.81% ROA-35.30% Short Interest5.95M Perf Year21.82%
Cash/sh2.01 P/C0.27 EPS next 5Y- ROE-51.87% 52W Range0.36 - 5.83 Perf YTD-0.19%
Dividend Est.- P/FCF- EPS past 5Y-52.56% ROI-35.50% 52W High-90.81% Beta1.25
Dividend TTM- Quick Ratio41.10 Sales past 5Y0.00% Gross Margin- 52W Low47.66% ATR (14)0.05
Dividend Ex-Date- Current Ratio41.10 EPS Y/Y TTM76.49% Oper. Margin0.00% RSI (14)39.52 Volatility7.59% 7.67%
Employees29 Debt/Eq0.38 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.50
Option/ShortYes / Yes LT Debt/Eq0.38 EPS Q/Q51.66% Payout- Rel Volume0.81 Prev Close0.57
Sales Surprise- EPS Surprise19.46% Sales Q/Q- EarningsAug 06 BMO Avg Volume1.17M Price0.54
SMA20-4.74% SMA50-11.65% SMA200-79.45% Trades Volume952,666 Change-6.67%
Date Action Analyst Rating Change Price Target Change
May-31-24Initiated Piper Sandler Overweight $10
May-14-24Initiated Stephens Overweight $8
Mar-01-24Initiated JMP Securities Mkt Outperform $7
May-30-23Upgrade SVB Securities Market Perform → Outperform $5 → $8
Dec-23-21Initiated H.C. Wainwright Buy $12
Oct-10-24 12:00PM
Oct-09-24 01:02PM
Sep-24-24 07:31AM
Sep-23-24 07:30AM
Sep-03-24 07:30AM
07:12AM Loading…
Aug-07-24 07:12AM
Aug-06-24 07:10AM
07:00AM
Jun-27-24 07:30AM
May-27-24 06:35AM
May-14-24 07:53AM
May-07-24 07:30AM
May-06-24 02:06PM
May-02-24 01:54PM
07:30AM
06:40AM Loading…
Apr-11-24 06:40AM
Apr-08-24 04:30PM
Mar-28-24 01:15PM
Mar-07-24 01:54PM
Mar-06-24 02:51PM
07:30AM
Mar-05-24 06:00PM
04:50PM
Mar-04-24 07:30AM
Feb-28-24 07:30AM
Feb-23-24 09:17AM
Feb-22-24 07:30AM
Jan-22-24 07:30AM
Jan-09-24 10:25AM
Jan-05-24 07:30AM
07:30AM Loading…
Nov-22-23 07:30AM
Nov-02-23 09:40AM
07:30AM
Sep-05-23 07:30AM
Aug-16-23 07:30AM
Aug-03-23 07:30AM
Jul-13-23 08:00AM
Jun-08-23 10:41PM
04:01PM
Jun-03-23 09:00AM
May-19-23 06:54AM
May-15-23 07:30AM
Apr-26-23 04:05PM
Apr-17-23 10:15AM
Mar-23-23 09:40AM
Mar-14-23 04:30PM
Mar-09-23 07:30AM
Mar-01-23 07:00AM
Feb-08-23 07:00AM
Jan-09-23 07:30AM
Jan-06-23 08:15AM
Nov-30-22 07:30AM
Nov-03-22 07:30AM
Aug-12-22 09:30AM
Aug-04-22 07:30AM
Aug-03-22 08:00AM
Jul-28-22 08:50AM
08:45AM
Jul-14-22 08:45AM
Jun-01-22 07:30AM
May-26-22 05:05PM
08:27AM
May-25-22 07:30AM
May-05-22 07:30AM
Apr-27-22 10:05AM
Mar-24-22 01:12PM
Mar-14-22 07:00AM
Mar-03-22 07:30AM
Mar-01-22 07:00AM
Jan-10-22 07:00AM
Jan-06-22 08:00AM
Jan-05-22 08:00AM
Dec-16-21 09:14AM
Nov-18-21 08:00AM
Nov-12-21 07:30AM
Oct-20-21 07:00AM
Oct-14-21 07:00AM
Sep-25-21 09:52AM
Sep-07-21 07:00AM
Aug-12-21 04:05PM
Aug-04-21 07:00AM
Jun-24-21 08:44PM
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm's program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.